Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Understand the dynamics of wealth building by comparing real estate and stocks. Find out which option may yield faster returns for your investments.
26,865 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Robinhood shares surged after several brokerages initiated coverage with Buy ratings as the broader crypto rebound li...
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
SpaceX leaps past the $2 trillion mark as it eyes a spot in the Nasdaq-100, triggering intense debate about the susta...
Celcuity stock popped today after the company released its 2025 results, showing a tighter quarterly loss despite no ...
After a dramatic fall, Canopy Growth has staged a cautious comeback. This article breaks down whether canopy growth s...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Broadcom stock rallied Thursday morning, delivering a notable move for a semiconductor leader. This article breaks do...
Canadian traders face a fast-moving market in May 2026 as platforms race to lower costs and boost real-time data. Thi...
AI stocks have dominated headlines, but long-term winners often come from durable franchises. This article explains w...
This earnings season produced a mix of wins and misses. We break down what worked what didn't, with actionable tips y...
When a rocket-ride valuation grabs headlines, it’s easy to chase the hype. This guide breaks down spacex's market qui...